Home  /   Media  /  Stock exchange & press releases  /  2018

Stock Exchange & Press Releases 2018

Print Print this release
June 04, 2018

Bittium exhibits its innovative products and solutions for neuroscience and cardiology at 8th Mismatch Negativity conference 2018

Press release

Free for publication on June 4, 2018 at 1.30pm (CEST +1)

Bittium exhibits its innovative products and solutions for neuroscience and cardiology at 8th Mismatch Negativity conference 2018

Oulu, Finland, June 4, 2018 – Bittium exhibits its innovative products and solutions for neuroscience and cardiology at 8th Mismatch Negativity conference (MMN) 2018 on June 12-15 in Helsinki, Finland. At the event Bittium will showcase the recently European CE medical approved wireless Bittium BrainStatus™ EEG amplifier and electrode headband meant for real-time brain electrical activity monitoring and Bittium NeurOne™ monitoring solution for brain electrical activity measurement. Also presented are the Bittium Faros™ cardiac ECG signal measuring and monitoring devices.

Products and solutions exhibited at the conference are:

  • Bittium BrainStatus is a wireless compact EEG amplifier, which is used together with a disposable easy and quick to wear Bittium BrainStatus electrode headband for example to diagnose epileptic seizures and brain stroke. Bittium BrainStatus enables quick measurement in field conditions as well as in hospitals, thus making the treatment process of the patient faster. Bittium BrainStatus can be used for wireless real-time remote EEG monitoring or data can be recorded to the device memory.
  • Bittium NeurOne is one of the quickest and most accurate EEG measuring devices in the world designed for clinical and research use. Bittium NeurOne system enables fully synchronized group measuring of up to 30 persons simultaneously for example in different types of psychological studies. The solution is optimized for use with transcranial magnetic stimulators (TMS-EEG), with optional possibility to use it during magnetic resonance imaging procedures (fMRI-EEG).
  • Bittium Faros is a versatile ECG device that is used for early detection of cardiac abnormalities in everyday life. Bittium Faros is ultra-small and lightweight, which enables precise long-term full disclosure ECG measurements for long-term Holtering, cardiac event monitoring, mobile cardiac telemetry and assessing autonomic nervous system functions.

Bittium Faros outpatient monitoring solutions include several software options for cardiac monitoring. The built-in arrhythmia detection algorithms of the Bittium Faros device are used for event recording and mobile event monitoring. This technology enables earlier repatriation of patients and even better ability to react to potentially emerging arrhythmias faster.

Further information:

Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 40 344 5466

Distribution:
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2017 were EUR 51.6 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com